top of page

Search Results

Results found for "opioid signaling"

  • Inside Out: Mapping GPCRs from Membrane Codes to Market Moves

    GPCR, we’re decoding arrestin-driven signaling and spotlighting the tools to match.   phosphorylation barcodes shape arrestin engagement, a biased NTSR1 modulator targets pain without the need for opioids , and a real-time lipid probe tracks early signaling events.   Terry Kenakin, these five modules reveal how location bias, intracellular signaling, and ligand kinetics

  • Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...

    monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS)-stimulator of interferon genes (STING) signaling This study unveiled a new antifibrotic cGAS/STING signaling pathway that suppresses pathological angiogenesis Meanwhile, cGAS deletion upregulated profibrotic Yes-associated protein (YAP) signaling in endothelial Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717, Together, our data support that activation of cGAS/STING signaling mitigates organ fibrosis and suppresses

  • Exploring pharmacological inhibition of G q/11 as an analgesic strategy

    August 2022 "Background and purpose: Misuse of opioids has greatly affected our society. One potential solution is to develop analgesics that act at targets other than opioid receptors. These can be used either as stand-alone therapeutics or to improve the safety profile of opioid drugs proteins by G-protein coupled receptors has pro-nociceptive properties, suggesting that blockade of Gq/11 signalling

  • Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids

    7 pass transmembrane domain, Class F GPCR family protein) plays a crucial role in the Hedgehog (HH) signaling In the absence of HH signaling, SMO is inhibited by Patched 1 (PTC1; a 12 pass transmembrane domain protein

  • TLR4 biased small molecule modulators

    Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors The biased signaling modulation of non-GPCR receptors has yet to be exploited. receptor 4 (TLR4) is one such non-GPCR receptor, which involves MyD88-dependent and TRIF-dependent signaling Small molecules biasedly modulating the TLR4 signaling axis not only provide probes to fine-tune receptor conformation and signaling but also provide an opportunity to identify promising drug candidates.

  • Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..

    We then demonstrate that sub-cellular localization and alternative signaling pathways may be responsible

  • New Podcast, Sweet Structures & $2.2B GPCR Moves

    We’re also tracking biased signaling in Class B GPCRs, the membrane-driven modulation of mGluR2, and Ben Clements   In Episode 166, Ben Clements dives into opioid pharmacology, GPCR-targeted PAMs, and how Biased signalling of Class B G protein-coupled receptor-targeted therapeutics .  

  • Dopamine activates astrocytes in prefrontal cortex via α1-adrenergic receptors

    However, basic physiology of PFC astrocytes, including which neuromodulatory signals they respond to Here, we characterize divergent signaling signatures in mouse astrocytes of the PFC and primary sensory Instead, fast calcium signals in PFC astrocytes are time locked to dopamine release and are mediated Thus, we identify astrocytes as active players in dopaminergic signaling in the PFC, contributing to

  • Advancements in G protein-coupled receptor biosensors to study GPCR-G protein coupling

    October 2022 "Enzymatic and cellular signalling biosensors are used to decipher the activities of complex selectivity, with an emphasis on sensors measuring receptor association and activation of heterotrimeric signalling

  • 📰 GPCR Weekly News, April 1 to 7, 2024

    David A Cooper, David Minh, et al., for their research on Intracellular pocket conformations, determine signaling through the μ opioid receptor. Let’s dive into the Classified GPCR News from April 1st to 7th, 2024 GPCR Activation and Signaling GPRASP1 Ca2+ release, exocytosis, and pancreatic tissue damage Intracellular pocket conformations determine signaling 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling

  • Dr. GPCR University registration is now open! Secure your spot now!

    Calebiro, Michael Decker, et al. for their study on Design, Synthesis, and Characterization of New δ Opioid Let’s dive into the Classified GPCR News from July 22 to 28, 2024 GPCR Activation and Signaling Activating Inverse Regulation of C-C Chemokine Receptor 3 Oligomerization by Downstream Proteins Indicates Biased Signal for diabetes treatment GPCRs in Neuroscience Astrocytes control quiescent NSC reactivation via GPCR signaling-mediated targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation Signaling

  • 📰 GPCR Weekly News, March 27 to April 4, 2023

    GPCR Symposium on GPCR Activation and Signaling held on May 19th, 2023. Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia. Gαi-derived peptide binds the µ-opioid receptor. Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2.

  • Integrative model of the FSH receptor reveals the structural role of the flexible hinge region

    How this HR is involved in hormone binding and signal transduction is still an open question. The models are expected to allow for testable hypotheses about signal transduction and drug development

  • 📰 GPCR Weekly News, May 22 to 28, 2023

    GPCR Activation and Signaling The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation Multiple Subthreshold GPCR Signals Combined by the G-Proteins Gαq and Gαs Activate the Caenorhabditis The intertwining roles of caveolin, oxytocin receptor, and the associated signalling pathways in prostate Your body naturally produces opioids without causing addiction or overdose – studying how this process (June 28 - 30, 2023) FREE 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July

  • Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...

    Ca2+ (Ca2+o ) via a dimeric extracellular Venus flytrap (VFT) unit that activates G protein-dependent signaling corresponding to heterozygous familial hypocalciuric hypercalcemia type-1 (FHH-1), supported maximal signaling In contrast, a single WT HH bundle was insufficient for maximal signaling and there was no functional Finally, we observed that the Ca2+o -stimulated CaSR operated exclusively via signaling in-trans and not via combined in-trans and in-cis signaling.

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024

    in cardiac and endothelial cell function Protein Biochemist/Structural Biologist GPCR Activation and Signaling Beyond the classic GPCR: unraveling the role of GPR155 role in cholesterol sensing and signaling High-affinity of the M1 Receptor The cell adhesion molecule CD44 acts as a modulator of 5-HT7 receptor functions Signal profiles and spatial regulation of β-arrestin recruitment through Gβ5 and GRK3 at the μ-opioid receptor GPCR Binders, Drugs, and more Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free

  • Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to...

    October 2022 Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inverse agonism "Dimerization of beta 2-adrenergic receptor (β2-AR) has been observed across various physiologies. However, the function of dimeric β2-AR is still elusive. Here, we revealed that dimerization of β2-AR is responsible for the constitutive activity of β2-AR generating inverse agonism. Using a co-immunoimmobilization assay, we found that transient β2-AR dimers exist in a resting state, and the dimer was disrupted by the inverse agonists. A Gαs preferentially interacts with dimeric β2-AR, but not monomeric β2-AR, in a resting state, resulting in the production of a resting cAMP level. The formation of β2-AR dimers requires cholesterol on the plasma membrane. The cholesterol did not interfere with the agonist-induced activation of monomeric β2-AR, unlike the inverse agonists, implying that the cholesterol is a specific factor regulating the dimerization of β2-AR. Our model not only shows the function of dimeric β2-AR but also provides a molecular insight into the mechanism of the inverse agonism of β2-AR." Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter

  • VAMP2: a crucial player in the delivery of MOR to the synapse

    Some studies have suggested that VAMP2 may be involved in regulating dopamine D2 receptor signaling by In addition, VAMP2 can interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid with different fusion proteins and also this different molecular codes will be modulated by different opioids Conformational specificity of opioid receptors is determined by subcellular location irrespective of

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    The reagents are compatible with HTRF readers  and validated in GLP1R  and Mu opioid receptor (MOR)   pHSense™ is the latest addition to Revvity’s GPCR reagent portfolio , which supports every stage of the signaling

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    Terence Hébert , et al. for their work on Understanding the impact of nuclear-localized GPCRs on cellular signaling Postdoctoral Position Postdoctoral research position Senior or Lead Researcher   GPCR Activation and Signaling GPCRs on cellular signalling GRK2 is critical for the cleavage of the porcine embryo by regulating HSP90 Biosensors Reveals Functional Differences among Receptor Paralogs GPCRs in Neuroscience Opposing GPCR signaling Receptor 2 with a Versatile Intracellular Allosteric Probe Selective optogenetic inhibition of Gαq or Gαi signaling

  • 📰 GPCR Weekly News, June 10 to 16, 2024

    Teye Azietaku for his contributor article on Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling GPCR Activation and Signaling Emerging modes of regulation of neuromodulatory G protein-coupled receptors mGluR2/3 control synaptic glutamate time course at hippocampal CA1 synapses Regulator of G protein signaling behavioral reward, and susceptibility to relapse Alcohol consumption does not impact delta and kappa opioid GPCR Events, Meetings, and Webinars June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling

  • TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms

    August 2022 "The calcium-permeable cation channel TRPM3 can be activated by heat and the endogenous steroid pregnenolone sulfate. TRPM3's best understood function is its role as a peripheral noxious heat sensor in mice. However, the channel is expressed in various tissues and cell types including neurons as well as glial and epithelial cells. TRPM3 expression patterns differ between species and change during development. Furthermore, a plethora of TRPM3 variants that result from alternative splicing have been identified and the majority of these isoforms are yet to be characterized. Moreover, the mechanisms underlying regulation of TRPM3 are largely unexplored. In addition, a micro-RNA gene (miR-204) is located within the TRPM3 gene. This complexity makes it difficult to obtain a clear picture of TRPM3 characteristics. However, a clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic marker and therapeutic target. Therefore, the newest data related to TRPM3 have to be discussed and to be put in context as soon as possible to be up-to-date and to accelerate the translation from bench to bedside. The aim of this review is to highlight recent results and developments with particular focus on findings from studies involving ocular tissues and cells or peripheral neurons of rodents and humans." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    A Final Aha Moment: Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids

  • Search for safer pain relief advances with new engineered compounds

    November 2021 "Chronic use of most opioids causes tolerance; the new compounds avoid this and other unwanted new pain-relieving compounds that, like morphine and other drugs, provide relief via activation of opioid receptors, but without inducing many dangerous and unwanted side-effects that have driven opioid-related

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. GPCR Activation and Signaling How can we improve the measurement of receptor signaling bias? Phosphorylation barcodes direct biased chemokine signaling at CXCR3. Subcellular location defines GPCR signal transduction. Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development The pathway of opioid

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    Robert Lefkowitz for their work on GPCRs: from radioligand binding to cellular signaling Dr. Next week, on March 15th, we are hosting a symposium on GPCR activation and signaling. Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury GPCRs in of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach Opioid pathway Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-

  • What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024

    /Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry GPCR Activation and Signaling 3 ion channel Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling physiological implications Sphingosine-1-phosphate activates LRRC8 volume-regulated anion channels through Gβγ signalling Species GPCRs in Neuroscience Role of the GRK2/3 N-terminus in discriminating the endocytic effects of opioid Modelling and simulation of membrane proteins in a nutshell Ciliary length variations impact cilia-mediated signaling

  • Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!

    Mikel Garcia-Marcos for their excellent work on Protocol to investigate G protein-coupled receptor signaling Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position GPCR Activation and Signaling pathways in GPCR-mediated activation of Ca2+ mobilization in HEK293 cells Activation of polycystin-1 signaling via ABCB1 in keratinocytes GPCRs in Neuroscience Ventral tegmental area amylin / calcitonin receptor signaling recognition Structural basis of psychedelic LSD recognition at dopamine D1 receptor Structural basis of μ-opioid

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    GPCR Activation and Signaling Distinct beta-arrestin coupling and intracellular trafficking of metabotropic receptor homo- and heterodimers Structural basis of G protein-Coupled receptor CMKLR1 activation and signaling Binders, Drugs, and more Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid in alcohol use disorder GPCRs in Oncology and Immunology Regulator of G protein signaling protein 6 the A2A adenosine receptor Reviews, GPCRs, and more Structure, function and drug discovery of GPCR signaling

  • 📰 GPCR Weekly News, July 24 to July 30, 2023

    GPCR Activation and Signaling Endosome positioning coordinates spatially selective GPCR signaling. Development of a V5-tag-directed nanobody and its implementation as an intracellular biosensor of GPCR signalling Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat GPCRs in Neuroscience Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex

bottom of page